These questions help move the patient away from hype and toward safer, more informed care
yet, as we age, we all experience changes in memory, cognition and brain function
Curr Opin Endocrinol Diabetes Obes 25(1):6166
You can choose to inject it in your abdomen, thigh, or upper armwherever is most comfortable for you
For those exploring a non-injection alternative to GLP-1 medications, oral semaglutide has emerged as a promising option

Patients should be counseled to report severe abdominal pain immediately Gallbladder disease : Increased risk of cholelithiasis and cholecystitis, likely related to rapid weight loss Hypoglycemia : Risk is low when used alone but increases when combined with insulin or sulfonylureas Thyroid C-cell tumors : Based on rodent studies, these agents carry a boxed warning and are contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 Acute kidney injury : Can occur, particularly with dehydration from gastrointestinal side effects Diabetic retinopathy complications : Semaglutide may worsen diabetic retinopathy in patients with diabetes, particularly with rapid improvement in glucose control Severe gastrointestinal disease : Use with caution in patients with gastroparesis or severe gastrointestinal disease